Ilyang Pharmaceutical Co Ltd (007575) — Free Cash Flow Generation Index
Ilyang Pharmaceutical Co Ltd (007575) has a Free Cash Flow Generation Index of -0.47x as of June 2025. Free cash flow of ₩-1.06 Billion represents 0% of operating cash flow (₩2.26 Billion). See 007575 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Ilyang Pharmaceutical Co Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Ilyang Pharmaceutical Co Ltd across 11 annual periods. Explore Ilyang Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Ilyang Pharmaceutical Co Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for Ilyang Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Ilyang Pharmaceutical Co Ltd market cap and net worth.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.23x | ₩-35.01 Billion | ₩5.61 Billion | ₩40.62 Billion | ▼ -1270.6% |
| 2023 | 0.53x | ₩7.79 Billion | ₩14.62 Billion | ₩6.83 Billion | ▲ +69.6% |
| 2022 | 0.31x | ₩9.40 Billion | ₩29.94 Billion | ₩4.08 Billion | ▼ -53.9% |
| 2021 | 0.68x | ₩45.67 Billion | ₩67.02 Billion | ₩12.91 Billion | ▲ +19.2% |
| 2020 | 0.57x | ₩32.86 Billion | ₩57.48 Billion | ₩10.17 Billion | ▼ -25.6% |
| 2019 | 0.77x | ₩27.81 Billion | ₩36.19 Billion | ₩2.17 Billion | ▲ +36.6% |
| 2018 | 0.56x | ₩12.44 Billion | ₩22.12 Billion | ₩1.55 Billion | ▼ -19.2% |
| 2017 | 0.70x | ₩20.91 Billion | ₩30.03 Billion | ₩3.78 Billion | ▼ -49.6% |
| 2016 | 1.38x | ₩37.29 Billion | ₩26.98 Billion | ₩10.31 Billion | ▼ -1.2% |
| 2015 | 1.40x | ₩56.35 Billion | ₩40.27 Billion | ₩16.07 Billion | ▼ -19.8% |
| 2014 | 1.75x | ₩32.51 Billion | ₩18.63 Billion | ₩13.89 Billion | — |